Biotech funding remains stable amid AI investment surge
While AI startups have dominated venture capital flows, biotech has seen consistent annual funding. The sector has maintained investment levels between $36 billion and $40 billion globally for several years, unaffected by broader market shifts.
Sources: news.crunchbase.com
“This steadiness suggests biotech’s long-term R&D cycles make it less vulnerable to hype-driven funding swings than sectors like AI.”
Read the original reporting
The outlets below did the original reporting.
- Biotech Startup Investment Held Steady Even As AI Funding Surged — news.crunchbase.com
Related briefs
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.